Literature DB >> 24991000

Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.

Christopher Tipper1, Joseph G Sodroski2.   

Abstract

UNLABELLED: Following retrovirus entry, the viral capsid (CA) disassembles into its component capsid proteins. The rate of this uncoating process, which is regulated by CA-CA interactions and by the association of the capsid with host cell factors like cyclophilin A (CypA), can influence the efficiency of reverse transcription. Inspection of the CA sequences of lentiviruses reveals that several species of simian immunodeficiency viruses (SIVs) have lost the glycine-proline motif in the helix 4-5 loop important for CypA binding; instead, the helix 4-5 loop in these SIVs exhibits an increase in the number of glutamine residues. In this study, we investigated the role of these glutamine residues in SIVmac239 replication. Changes in these residues, particularly glutamine 89 and glutamine 92, resulted in a decreased efficiency of core condensation, decreased stability of the capsids in infected cells, and blocks to reverse transcription. In some cases, coexpression of two different CA mutants produced chimeric virions that exhibited higher infectivity than either parental mutant virus. For this complementation of infectivity, glutamine 89 was apparently required on one of the complementing pair of mutants and glutamine 92 on the other. Modeling suggests that glutamines 89 and 92 are located on the distal face of hexameric capsid spokes and thus are well positioned to contribute to interhexamer interactions. Requirements to evade host restriction factors like TRIMCyp may drive some SIV lineages to evolve means other than CypA binding to stabilize the capsid. One solution used by several SIV strains consists of glutamine-based bonding. IMPORTANCE: The retroviral capsid is an assembly of individual capsid proteins that surrounds the viral RNA. After a retrovirus enters a cell, the capsid must disassemble, or uncoat, at a proper rate. The interactions among capsid proteins contribute to this rate of uncoating. We found that some simian immunodeficiency viruses use arrays of glutamine residues, which can form hydrogen bonds efficiently, to keep their capsids stable. This strategy may allow these viruses to forego the use of capsid-stabilizing factors from the host cell, some of which have antiviral activity.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24991000      PMCID: PMC4178892          DOI: 10.1128/JVI.01388-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys.

Authors:  L Alexander; R S Veazey; S Czajak; M DeMaria; M Rosenzweig; A A Lackner; R C Desrosiers; V G Sasseville
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-01       Impact factor: 2.205

2.  High-resolution structure of a retroviral capsid hexameric amino-terminal domain.

Authors:  Gulnahar B Mortuza; Lesley F Haire; Anthony Stevens; Stephen J Smerdon; Jonathan P Stoye; Ian A Taylor
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

3.  Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm.

Authors:  Cristian Apetrei; Amitinder Kaur; Nicholas W Lerche; Michael Metzger; Ivona Pandrea; Johnny Hardcastle; Shelley Falkenstein; Rudolf Bohm; Jeffrey Koehler; Vicki Traina-Dorge; Tessa Williams; Silvija Staprans; Gail Plauche; Ronald S Veazey; Harold McClure; Andrew A Lackner; Bobby Gormus; David L Robertson; Preston A Marx
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.

Authors:  H M Rho; B Poiesz; F W Ruscetti; R C Gallo
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

5.  Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein.

Authors:  F F Vajdos; S Yoo; M Houseweart; W I Sundquist; C P Hill
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

6.  Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins.

Authors:  C Aberham; S Weber; W Phares
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function.

Authors:  In-Ja L Byeon; Xin Meng; Jinwon Jung; Gongpu Zhao; Ruifeng Yang; Jinwoo Ahn; Jiong Shi; Jason Concel; Christopher Aiken; Peijun Zhang; Angela M Gronenborn
Journal:  Cell       Date:  2009-11-13       Impact factor: 41.582

9.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.

Authors:  A Billich; F Hammerschmid; P Peichl; R Wenger; G Zenke; V Quesniaux; B Rosenwirth
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

Authors:  Elena Sokolskaja; David M Sayah; Jeremy Luban
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  3 in total

1.  Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo.

Authors:  Akatsuki Saito; Matthew S Henning; Erik Serrao; Brittany N Dubose; Samantha Teng; Jing Huang; Xiangming Li; Namiko Saito; Saumendra Prasad Roy; Mohammad Adnan Siddiqui; Jinwoo Ahn; Moriya Tsuji; Theodora Hatziioannou; Alan N Engelman; Masahiro Yamashita
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

2.  Analysis of the functional compatibility of SIV capsid sequences in the context of the FIV gag precursor.

Authors:  César A Ovejero; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

Review 3.  HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.

Authors:  Akatsuki Saito; Masahiro Yamashita
Journal:  Retrovirology       Date:  2021-10-26       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.